Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
China Pharma | CPHI | Nov 19, 2024 | 0.19 | +3.41 |
China Smallcap Index MSCI Ishares | ECNS | Nov 19, 2024 | 25.76 | -0.35 |
China SXT Pharmaceuticals | SXTC | Nov 19, 2024 | 0.39 | 0.00 |
China Technology ETF Guggenheim | CQQQ | Nov 19, 2024 | 40.72 | +0.54 |
China Yuchai International | CYD | Nov 19, 2024 | 8.92 | -1.11 |
ChipMOS Technologies ADR | IMOS | Nov 19, 2024 | 19.73 | +1.02 |
Chipotle Mexican Grill | CMG | Nov 19, 2024 | 58.73 | -0.14 |
Choice Hotels International | CHH | Nov 19, 2024 | 145.73 | -0.17 |
ChoiceOne Financial Services | COFS | Nov 19, 2024 | 35.88 | +1.27 |
Chord Energy | CHRD | Nov 19, 2024 | 127.97 | -1.81 |
Chromadex | CDXC | Nov 19, 2024 | 7.52 | +3.44 |
Chromocell Therapeutics | CHRO | Nov 19, 2024 | 0.54 | -14.13 |
CHS B Pref 1 | CHSCO | Nov 19, 2024 | 26.92 | +0.16 |
CHS B Pref 2 | CHSCN | Nov 19, 2024 | 25.43 | -0.27 |
CHS B Pref 4 | CHSCL | Nov 19, 2024 | 25.98 | -0.19 |
CHS B Reset Rate Pref 3 | CHSCM | Nov 19, 2024 | 25.19 | -0.08 |
CHS Pref | CHSCP | Nov 19, 2024 | 29.05 | +0.17 |
Chubb | CB | Nov 19, 2024 | 283.87 | -1.68 |
Chunghwa Telecom ADR | CHT | Nov 19, 2024 | 38.04 | +0.48 |
Church & Dwight | CHD | Nov 19, 2024 | 110.92 | +0.57 |
Churchill Capital IX A | CCIX | Nov 19, 2024 | 10.07 | +0.15 |
Churchill Capital IX Unit | CCIXU | Nov 19, 2024 | 10.20 | 0.00 |
Churchill Capital Vii | CVIIU | Nov 19, 2024 | 9.60 | 0.00 |
Churchill Downs | CHDN | Nov 19, 2024 | 138.74 | -0.08 |
Chuys | CHUY | Nov 19, 2024 | 37.48 | 0.00 |
CI&T | CINT | Nov 19, 2024 | 6.66 | +3.42 |
Cia Energetica De Minas Gerais Cemig ADR | CIG-C | Nov 19, 2024 | 2.59 | +0.39 |
Cia Energetica De Minas Gerais Pref ADR | CIG | Nov 19, 2024 | 2.04 | +2.51 |
Cibus A | CBUS | Nov 19, 2024 | 4.34 | +3.09 |
Cidara Therapeutics | CDTX | Nov 19, 2024 | 15.63 | +4.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.